Determinants of concordance in clinically relevant genes (CRG) from synchronously acquired tumor biopsies (tBx) and ctDNA in metastatic breast cancer (MBC).

Authors

null

Mafalda Oliveira

Medical Oncology Department, Breast Cancer Group, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Mafalda Oliveira , Fiorella Ruiz-Pace , Judit Matito , Raquel Perez-Lopez , Anna Suñol , Meritxell Bellet , Santiago Escriva-de-Romani , Esther Zamora , Patricia Gomez , Laia Garrigós , Marta Capelán , Miriam Arumí , Carolina Ortiz , Fabiola Amair-Pinedo , Francesco M Mancuso , Martin Espinosa-Bravo , Paolo Nuciforo , Rodrigo Dienstmann , Ana Vivancos , Cristina Saura

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Other Breast Cancer Subtypes

Citation

J Clin Oncol 37, 2019 (suppl; abstr 1075)

DOI

10.1200/JCO.2019.37.15_suppl.1075

Abstract #

1075

Poster Bd #

156

Abstract Disclosures

Similar Posters

Poster

2018 ASCO Annual Meeting

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

First Author: Razelle Kurzrock

Poster

2014 ASCO Annual Meeting

Advanced or recurrent endometrial cancer (EC) and co-occurring mutations in multiple oncogenic pathways.

Advanced or recurrent endometrial cancer (EC) and co-occurring mutations in multiple oncogenic pathways.

First Author: Alexandra Leary